Accretive Health
AH
AH was delisted on the 14th of March, 2014.
12 hedge funds and large institutions have $79.4M invested in Accretive Health in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 58 closing their positions.
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
80% less capital invested
Capital invested by funds: $404M → $79.4M (-$324M)
82% less funds holding
Funds holding: 66 → 12 (-54)
93% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Breithorn Capital Management
New York
|
+$1.6M |
| 2 |
ECM
EII Capital Management
New York
|
+$959K |
| 3 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$175K |
| 4 |
Neuberger Berman Group
New York
|
+$104K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$117M |
| 2 |
ICM
Indaba Capital Management
San Francisco,
California
|
-$28.9M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$24.5M |
| 4 |
MCO
MAK Capital One
New York
|
-$20.1M |
| 5 |
ClearBridge Investments
New York
|
-$17.5M |
AH Hedge Fund Activity: Q2 2014 in Review
12 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q2 2014, worth a combined $79.4M — down 80% from $404M a quarter earlier.
Sellers outnumbered buyers: 58 funds closed out of AH and 4 opened new positions — a net loss of 54 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Breithorn Capital Management, opening a new position worth an estimated $1.6M. The largest seller was Fidelity Investments, exiting entirely with an estimated $117M sold.
- 12 institutional investors held Accretive Health (AH) as of Q2 2014, down from 66 in Q1 2014.
- Funds reported $79.4M of Accretive Health stock for Q2 2014, down 80% quarter-over-quarter.
- 4 funds opened new Accretive Health positions in Q2 2014 and 58 closed out, a net change of -54 holders.
- The largest Accretive Health buyer in Q2 2014 was Breithorn Capital Management, an estimated $1.6M added.
- The largest Accretive Health seller in Q2 2014 was Fidelity Investments, an estimated $117M sold.
Based on aggregated 13F filings for Q2 2014.